Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies.

Dubey D, David WS, Amato AA, Reynolds KL, Clement NF, Chute DF, Cohen JV, Lawrence DP, Mooradian MJ, Sullivan RJ, Guidon AC.

Neurology. 2019 Aug 12. pii: 10.1212/WNL.0000000000008091. doi: 10.1212/WNL.0000000000008091. [Epub ahead of print]

PMID:
31405908
2.

Direct-acting antiviral therapy slows kidney function decline in patients with Hepatitis C virus infection and chronic kidney disease.

Sise ME, Chute DF, Oppong Y, Davis MI, Long JD, Silva ST, Rusibamayila N, Jean-Francois D, Raji S, Zhao S, Thadhani R, Chung RT.

Kidney Int. 2019 May 15. pii: S0085-2538(19)30508-3. doi: 10.1016/j.kint.2019.04.030. [Epub ahead of print]

PMID:
31337501
3.

Process of selecting and educating HCV-uninfected kidney waiting-list candidates for HCV-infected kidney transplantation.

Sise ME, Wojciechowski D, Chute DF, Gustafson J, Chung RT, Williams WW, Elias N.

Artif Organs. 2019 Apr 19. doi: 10.1111/aor.13473. [Epub ahead of print]

PMID:
31001828
4.

Transplantation of hepatitis C virus infected kidneys into hepatitis C virus uninfected recipients.

Sise ME, Chute DF, Gustafson JL, Wojciechowski D, Elias N, Chung RT, Williams WW.

Hemodial Int. 2018 Apr;22 Suppl 1:S71-S80. doi: 10.1111/hdi.12650. Review.

PMID:
29694722
5.

Effect of the Opioid Crisis on the Donor Pool for Kidney Transplantation: An Analysis of National Kidney Deceased Donor Trends from 2010-2016.

Chute DF, Sise ME.

Am J Nephrol. 2018;47(2):84-93. doi: 10.1159/000486516. Epub 2018 Feb 13.

PMID:
29439266
6.

Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient.

Chute DF, Chung RT, Sise ME.

Kidney Int. 2018 Mar;93(3):560-567. doi: 10.1016/j.kint.2017.10.024. Epub 2018 Jan 9. Review.

PMID:
29325996
7.

When and how can nephrologists treat hepatitis C virus infection in dialysis patients?

Davis MI, Chute DF, Chung RT, Sise ME.

Semin Dial. 2018 Jan;31(1):26-36. doi: 10.1111/sdi.12650. Epub 2017 Sep 18. Review.

PMID:
28925068
8.

Effect of Sofosbuvir-Based Hepatitis C Virus Therapy on Kidney Function in Patients with CKD.

Sise ME, Backman E, Ortiz GA, Hundemer GL, Ufere NN, Chute DF, Brancale J, Xu D, Wisocky J, Lin MV, Kim AY, Thadhani R, Chung RT.

Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1615-1623. doi: 10.2215/CJN.02510317. Epub 2017 Sep 7.

Supplemental Content

Loading ...
Support Center